
The FDA’s new CBER Safety Council separates post-market biologics safety review from approvals, raising oversight for cell and gene therapy developers.
Learn how to use KPIs like Overall Equipment Effectiveness (OEE) to identify and close productivity gaps in batch manufacturing and improve product quality.





